Fig. 2From: Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean childrenScatterplots of estimated joint density of incremental costs and incremental effects (treatment successes) by bootstrap re-sampling of AN relative to AL for children with Plasmodium falciparum malaria (left) and Plasmodium vivax malaria (right) in a usual care setting in Papua New Guinea 2011–2013. The ◊ represents the point estimate for incremental cost and incremental effect (treatment success)Back to article page